Making the case for advance provision of mifepristone and misoprostol for abortion in the United States

Ehrenreich, Katherine; Biggs, M. Antonia; Grossman, Daniel

doi:10.1136/bmjsrh-2021-201321

Cited by 9 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Where abortion is legal, state residents may be subject to care delays due to an inundation of people coming from out of state for services 5 6. One strategy to ensure access is the advance provision of abortion pills, whereby a clinician dispenses pills to a person, before an undesired pregnancy, in case of future need 7 8. This strategy has the potential to reduce access barriers for those seeking an abortion before 12 weeks’ gestation, when most people access abortion 9.…”

Section: Introductionmentioning

confidence: 99%

Interest in advance provision of abortion pills: a national survey of potential users in the USA

Lerma

Blumenthal

2023

BMJ Sex Reprod Health

View full text Add to dashboard Cite

ObjectiveTo assess interest in clinician-administered advance provision of abortion pills among potential users in the USA.MethodsUsing social media advertisements, we recruited people living in the USA who were aged 18–45 years and assigned female at birth, who were not pregnant or planning pregnancy, for an online survey on reproductive health experiences and attitudes. We explored interest in advance provision of abortion pills, participant characteristics, including demographics and pregnancy history, contraceptive use, abortion knowledge and comfort, and healthcare system distrust. We used descriptive statistics to assess interest in advance provision, and ordinal regression modelling to evaluate differences in interest controlling for age, pregnancy history, contraceptive use, familiarity and comfort with medication abortion, and healthcare system distrust, reporting adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs).ResultsFrom January-February 2022, we recruited 634 diverse respondents from 48 states, among whom 65% were interested, 12% neutral, and 23% disinterested in advance provision. There were no differences among interest groups by US region, race/ethnicity, or income. In the model, variables associated with interest included being aged 18–24 years (aOR 1.9, 95% CI 1.0 to 3.4) versus 35–45 years, using a tier 1 (permanent or long-acting reversible) or tier 2 (short-acting hormonal) contraceptive method (aOR 2.3, 95% CI 1.2 to 4.1, and aOR 2.2, 95% CI 1.2 to 3.9, respectively) versus no contraception, being familiar or comfortable with the medication abortion process (aOR 4.2, 95% CI 2.8 to 6.2, and aOR 17.1, 95% CI 10.0 to 29.0, respectively), and having high healthcare system distrust (aOR 2.2, 95% CI 1.0 to 4.4) versus low distrust.ConclusionAs abortion access becomes more constrained, strategies are needed to ensure timely access. Advance provision is of interest to the majority of those surveyed and warrants further policy and logistical exploration.

show abstract

Section: Introductionmentioning

confidence: 99%

Interest in advance provision of abortion pills: a national survey of potential users in the USA

Lerma

Blumenthal

2023

BMJ Sex Reprod Health

View full text Add to dashboard Cite

show abstract

“…Advance provision of abortion medications is the prescription of mifepristone and misoprostol before pregnancy occurs . Physicians in the US do not routinely engage in advance provision, yet there is considerable interest among US populations .…”

mentioning

confidence: 99%

Advance Provision of Mifepristone and Misoprostol via Online Telemedicine in the US

Aiken,

Starling,

van Blitterswijk

et al. 2024

JAMA Intern Med

View full text Add to dashboard Cite

show abstract

“…Plan C also informed people about providers offering abortion pills in advance of pregnancy. In December of 2021, researchers at Advancing New Standards in Reproductive Health published an editorial supporting the safety of an advance provision model of medication abortion(Ehrenreich, Biggs and Grossman 2021).Finally, people used misoprostol alone, which is a very safe and effective way to end pregnancy(Raymond, Harrison, and Weaver 2019). Brazilian women in the 1980s first began end pregnancies after they noticed the drug's label warning against use while pregnant because it could cause a miscarriage.…”

mentioning

confidence: 99%

History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion

Baker

2023

Journal of Health Politics, Policy and Law

View full text Add to dashboard Cite

This article examines the decades-long campaign to increase access to abortion pills in the United States, including advocates’ work to win U.S. Food and Drug Administration approval of mifepristone and misoprostol for abortion, the continuing restrictions on mifepristone and the multiple strategies advocates have pursued to challenge these restrictions, including lobbying the FDA to remove the restrictions, obtaining a limited research exemption from FDA restrictions and suing the FDA during the COVID pandemic. The article pays particular attention to influence of research conducted on the safety and efficacy of medication abortion as well as research on the impact of increased availability of abortion pills through telemedicine during the pandemic. The article also addresses self-managed abortion, where people obtain and use mifepristone and/or misoprostol outside of the formal healthcare system, and documents the growing network of organizations providing logistical, medical and legal support for people self-managing abortion. The article concludes with reflections on the role abortion pills might play in the post-Roe era amid increasingly divergent abortion access trends across different regions of the United States.

show abstract

Making the case for advance provision of mifepristone and misoprostol for abortion in the United States

Cited by 9 publications

References 28 publications

Interest in advance provision of abortion pills: a national survey of potential users in the USA

Interest in advance provision of abortion pills: a national survey of potential users in the USA

Advance Provision of Mifepristone and Misoprostol via Online Telemedicine in the US

History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion

Contact Info

Product

Resources

About